Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Verrica Pharmaceuticals buy Royal Bank of Canada

Verrica Pharmaceuticals
Start price
€0.99
18:00 / 50%
Target price
€10.03
04.10.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 04.10.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time.
Performance without dividends (%)
Name 1w
Verrica Pharmaceuticals -
iShares Core DAX® -1.471%
iShares Nasdaq 100 -0.486%
iShares Nikkei 225® -2.115%
iShares S&P 500 0.394%

Comments by Royal_Bank_of_Canada for this prediction

In the thread Discuss Verrica Pharmaceuticals
Prediction Buy
Perf. (%) -
Target price 10.033
Change
Ends at 04.10.25

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target lowered by analysts at Royal Bank of Canada from $13.00 to $11.00. They now have an "outperform" rating on the stock.
Ratings data for VRCA provided by MarketBeat

Royal Bank of Canada 
0
Report Share
18:00

Stopped prediction by Royal_Bank_of_Canada for Verrica Pharmaceuticals

buy
Verrica Pharmaceuticals

Start price
Target price
Perf. (%)
€2.60
15.08.24
€11.83
15.08.25
-52.04%
03.10.24

Royal Bank of Canada 
15.08.24 50%